Udroiu Ion, Marinaccio Jessica, Goffi Romina Stella, Micheli Emanuela, Sgura Antonella
Dipartimento di Scienze, Università degli Studi "Roma Tre", Italy.
FEBS Lett. 2025 Apr;599(7):989-1005. doi: 10.1002/1873-3468.15087. Epub 2025 Jan 1.
Some tumors employ a mechanism called alternative lengthening of telomeres (ALT) to counteract telomere shortening-induced replicative senescence. Several hallmarks are used to identify cell lines and tumors as ALT-positive. Here, we analyzed a panel of ALT-positive and -negative cancer cell lines to investigate the specificity and sensibility of ALT-associated markers. We found that all the markers showed high sensitivity, indicating that cells not showing ALT markers are not ALT cells. Conversely, specificity varied significantly, i.e., many markers yield false positives. Detection of false positives may have influenced previous estimations of ALT incidence among tumors. Moreover, claims on the 'coexistence' of ALT and telomerase perhaps should be reconsidered. The findings prompt further study into the nature of these markers and their roles as either part of the ALT machinery or as by-products.
一些肿瘤采用一种称为端粒替代延长(ALT)的机制来对抗端粒缩短诱导的复制性衰老。有几个特征被用来鉴定细胞系和肿瘤是否为ALT阳性。在这里,我们分析了一组ALT阳性和阴性癌细胞系,以研究ALT相关标志物的特异性和敏感性。我们发现所有标志物都显示出高敏感性,这表明未显示ALT标志物的细胞不是ALT细胞。相反,特异性差异很大,即许多标志物会产生假阳性。假阳性的检测可能影响了先前对肿瘤中ALT发生率的估计。此外,关于ALT和端粒酶“共存”的说法或许应该重新考虑。这些发现促使人们进一步研究这些标志物的本质以及它们作为ALT机制的一部分或作为副产物所起的作用。